Wird geladen...
Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients with stage I–III breast cancer who were treated w...
Gespeichert in:
| Veröffentlicht in: | J Natl Cancer Inst |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6592411/ https://ncbi.nlm.nih.gov/pubmed/18695137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn233 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|